1. GlaxoSmithKline Spin-Off to Create Healthcare Giant Worth Estimated £40 Bil

    GlaxoSmithKline Spin-Off to Create Healthcare Giant Worth Estimated £40 Bil

    LONDON – British drugs giant GlaxoSmithKline on Monday demerges its newly named consumer healthcare unit Haleon, resulting in ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. This will be the largest London stock market listing in a decade, with the new company becoming a big beast with a new skin in the consumer goods world.
    2. The idea is that a more focused consumer business will help boost sales.
  3. Topics Mentioned

  4. Authors